Drug recall
Umary Acido Hialuronico, Suplemento Alimenticio, 850 mg caplets, packaged in 30-count bottles.
FDA recall event 94978 · Class I · SoloVital
Key facts
| Event ID | 94978 |
|---|---|
| Recall numbers | D-0620-2024 |
| Recalling firm | SoloVital |
| Product type | Drugs |
| Products | Umary Acido Hialuronico, Suplemento Alimenticio, 850 mg caplets, packaged in 30-count bottles. |
| Classification | Class I |
| Status | Ongoing |
| Voluntary or mandated | Voluntary: Firm Initiated |
| Reason for recall | Marketed without an Approved NDA/ANDA: FDA analysis found product to be tainted with undeclared Diclofenac and Omeprazole. |
| Initiation date | Jul 12, 2024 |
| Report date | Aug 7, 2024 |
| City | Chula Vista |
| State | CA |
| Country | United States |
| FEI number | 3030905367 |
At a glance
- 1–9 Products in this recall
- None FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: